List of Drugs* (as of 1 April 2021)
Active Ingredient(s),Dosage Form,Strength(s),Subsidy Class,Clinical Indication
Abacavir & Lamivudine,Tablet,Abacavir 600 mg + Lamivudine 300 mg,SDL, 
"Abacavir, Dolutegravir & Lamivudine",Tablet,Abacavir 600 mg + Dolutegravir 50 mg + Lamivudine 300 mg,SDL, 
Abiraterone Acetate (Abiranat),Tablet,250 mg,SDL,
Absolute Alcohol ,Injection,100%,SDL,
Acetazolamide,Tablet,250 mg,SDL,
Acetic acid,Ear drops,"2%, 3%, 4%, 5%",SDL,
Acetylcysteine,Injection,5 g/25 mL,SDL,
Aciclovir,Concentrate for infusion,250 mg/10 mL,SDL,
Aciclovir,Infusion,250 mg,SDL,
Aciclovir,Eye ointment,3%,SDL,
Acitretin,Capsule,"10 mg, 25 mg",SDL,
Adalimumab Biosimilar (Amgevita),Prefilled autoinjector,40 mg/0.8 mL,SDL, 
Adalimumab Biosimilar (Amgevita),Prefilled syringe,"20 mg/0.4 mL, 40 mg/0.8 mL",SDL, 
Adefovir Dipivoxil ,Tablet,10 mg,SDL,
Adrenaline,Injection,"1:1,000 (1 mg/mL), 1:10,000 (1 mg/10 mL)",SDL,
Albendazole,Oral suspension,400 mg/10 mL,SDL,
Albendazole,Tablet,400 mg,SDL,
Alendronic Acid,Tablet,"10 mg, 70 mg",SDL,
Alendronic Acid & Colecalciferol ,Tablet,"Alendronic Acid 70 mg + Colecalciferol 2,800 international units, Alendronic Acid 70 mg + Colecalciferol 5,600 international units",MAF,"1) For patients with osteoporosis (T-score ≤ -2.5)
           2) For patients with osteopenia (T-score ≤ -1.5) and a history of non-trauma induced fracture"
Alfacalcidol,Capsule,"0.25 mcg, 1 mcg",SDL,
Alfacalcidol,Oral drops,2 mcg/mL,SDL,
Alfacalcidol,Tablet,"0.25 mcg, 1 mcg",SDL,
Alfuzosin Hydrochloride,Tablet,10 mg,SDL,
Allopurinol,Tablet,"100 mg, 300 mg",SDL,
Alteplase,Infusion,50 mg/50 mL,SDL,
Aluminium Hydroxide,Tablet,600 mg,SDL,
"Aluminium Hydroxide, Magnesium Trisilicate & Simeticone",Chewable tablet,Aluminium Hydroxide 250 mg + Magnesium Trisilicate 250 mg + Simeticone 30 mg ,SDL,
"Aluminium Hydroxide, Magnesium Trisilicate & Simeticone",Oral suspension,Aluminium Hydroxide 400 mg/5 mL + Magnesium Trisilicate 400 mg/5 mL + Simeticone 30 mg/5 mL ,SDL,
Aluminium Oxide ,Oral suspension,4%,SDL,
Ambrisentan,Tablet,"5 mg, 10 mg",MAF,Treatment of adults with a confirmed diagnosis of WHO Functional Class II or III pulmonary arterial hypertension (PAH) who have one of the following PAH aetiologies:• Idiopathic PAH• Heritable or familial PAH• PAH associated with connective tissue disease• Anorexigen-induced PAH• PAH associated with HIV infection
Amikacin ,Injection,500 mg/2 mL,SDL,
Amiloride & Hydrochlorothiazide,Tablet,Amiloride Hydrochloride 5 mg + Hydrochlorothiazide 50 mg,SDL,
Amino Acids,Infusion,"5%, 10%",SDL,
Aminophylline,Injection,250 mg/10 mL,SDL,
Amiodarone Hydrochloride,Injection,50 mg/mL,SDL,
Amiodarone Hydrochloride,Tablet,200 mg,SDL,
Amitriptyline,Tablet,"10 mg, 25 mg",SDL,
Amlodipine ,Tablet,"5 mg, 10 mg",SDL,
Amoxicillin,Capsule,250 mg,SDL,
Amoxicillin,Oral suspension,"125 mg/5 mL, 250 mg/5 mL",SDL,
Amoxicillin & Clavulanic Acid ,Injection,"Amoxicillin 500 mg + Clavulanic Acid 100 mg, Amoxicillin 1 g + Clavulanic Acid 200 mg",SDL,
Amoxicillin & Clavulanic Acid ,Oral suspension,"Amoxicillin 200 mg/5 mL + Clavulanic Acid 28.5 mg/5 mL, Amoxicillin 600 mg/5 mL + Clavulanic Acid 42.9 mg/5 mL",SDL,
Amoxicillin & Clavulanic Acid ,Tablet,"Amoxicillin 500 mg + Clavulanic Acid 125 mg, Amoxicillin 875 mg + Clavulanic Acid 125 mg",SDL,
Amphotericin B,Injection,50 mg,SDL,
Amphotericin B,Eye drops,1 mg/mL,SDL,
Ampicillin,Injection,0.5 g,SDL,
Anastrozole,Tablet,1 mg,MAF,"Treatment of hormone receptor positive, postmenopausal women with early and advanced breast cancer"
Antazoline Hydrochloride & Tetryzoline Hydrochloride,Eye drops,Antazoline Hydrochloride 0.5 mg/mL + Tetryzoline Hydrochloride 0.4 mg/mL,SDL,
Anti-Rabies Immunoglubulin,Injection,300 units/2 mL,SDL,
Apixaban,Tablet,"2.5 mg, 5 mg",MAF,"1) Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF)* and CHA2DS2-VASc score of 1 or more for men, and 2 or more for women*This excludes patients with rheumatic mitral stenosis or prosthetic heart valves2) Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE in adults. MAF assistance does not apply to patients with isolated distal DVT"
Aprepitant,Capsule,80 mg,MAF,Prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
Aprepitant,Capsule,80 mg & 125 mg (Tripack),MAF,Prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
Aqueous Cream,Cream,Emulsifying Ointment 30% with either Chlorocresol 0.1% or Phenoxyethanol 0.1%,SDL,
Ascorbic Acid,Tablet,100 mg,SDL,
Ascorbic Acid ,Injection,"1 g/20 mL, 500 mg/5 mL ",SDL,
Aspirin,Tablet,"100 mg, 300 mg",SDL,
Atazanavir,Capsule,"200 mg, 300 mg",SDL, 
Atenolol,Tablet,"50 mg, 100 mg",SDL,
Atorvastatin,Tablet,"10 mg, 20 mg, 40 mg, 80 mg",SDL,
Atracurium,Injection,"25 mg/2.5 mL, 50 mg/5 mL",SDL,
Atropine Sulfate,Eye drops,"0.5%, 1%",SDL,
Atropine Sulfate ,Injection,0.6 mg/mL,SDL,
Azathioprine,Tablet,"25 mg, 50 mg",SDL,
Azithromycin ,Extended-release oral suspension,2 g,SDL,
Azithromycin ,Injection,500 mg,SDL,
Azithromycin ,Oral suspension,200 mg/5 mL,SDL,
Azithromycin ,Tablet,250 mg,SDL,
Bacillus Calmette-Guerin,Solution for intravesical use,"12.5 mg, 40 mg, 80 mg",SDL,
Baricitinib,Tablet,"2 mg, 4 mg",MAF,Checklist to be completedTreatment of adult patients with rheumatoid arthritis
Beclomethasone,Inhaler,250 mcg/dose,SDL,
Beclomethasone Dipropionate,Inhaler,50 mcg/dose,SDL,
Benzalkonium Chloride & Cetrimide ,Cream,Benzalkonium Chloride 0.01% + Cetrimide 0.2%,SDL,
Benzathine Benzylpenicillin,Injection,2.4 million international units,SDL,
Benztropine,Injection,2 mg/2 mL,SDL,
Benztropine Mesilate ,Tablet,2 mg,SDL,
Benzhexol Hydrochloride ,Tablet,2 mg,SDL,
Benzoyl Peroxide,Gel,"2.5%, 5%, 10%",SDL,
Benzoyl Peroxide ,Lotion,"5%, 10%",SDL,
Benzyl Benzoate,Topical emulsion,25%,SDL,
Benzylpenicillin Sodium,Eye drops (preservative-free),"2,500 international units/mL",SDL,
Benzylpenicillin Sodium ,Injection,"1 million international units, 5 million international units",SDL,
Betaine,Powder,180 g,MAF,"1) Treatment of classic homocysteinuria2) Treatment of homocysteinuria secondary to sulfite oxidase deficiency, methionine synthase deficiency or cobalamin-related remethylation pathway defect"
Betahistine Mesilate ,Tablet,6 mg,SDL,
Betamethasone (as Valerate) ,Scalp lotion,0.1%,SDL,
Betamethasone (as Valerate) ,Cream,"0.0125%, 0.025%, 0.05%, 0.1%",SDL,
Betamethasone (as Valerate) ,Ointment,"0.025%, 0.05%, 0.1%",SDL,
Betamethasone (as Valerate) & Clioquinol,Cream,"Betamethasone 0.025% + Clioquinol 3%, Betamethasone 0.05% + Clioquinol 3%, Betamethasone 0.1% + Clioquinol 3%
        ",SDL,
Betamethasone Sodium Phosphate,Eye/ear drops,0.1%,SDL,
Betamethasone Sodium Phosphate,Eye/ear drops,0.1%,SDL,
Betaxolol,Eye drops,0.25%,SDL,
Bethanechol Chloride ,Tablet,10 mg,SDL,
Bevacizumab,Intravitreal injection,25 mg/mL,MAF,"1) Treatment of adults with visual impairment due to neovascular (wet) age-related macular degeneration
           2) Treatment of adults with visual impairment due to macular oedema secondary to central or branch retinal vein occlusion
           3) Treatment of adults with visual impairment due to diabetic macular oedema"
Bisacodyl,Enteric-coated tablet,5 mg,SDL,
Bisacodyl,Rectal suppository,10 mg,SDL,
Bismuth Subcitrate,Tablet,120 mg,SDL,
Bismuth Subgallate,Rectal suppository,Bismuth Subgallate 200 mg + Zinc Oxide 120 mg,SDL,
Bismuth Subsalicylate,Tablet,262.5 mg,SDL, 
Bisoprolol Fumarate ,Tablet,"2.5 mg, 5 mg",SDL,
Bleomycin,Injection,"15,000 international units (USP 15 units)",SDL,
Blinatumomab,Infusion,35 mcg,MAF,"Treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL) for a maximum of 2 cycles for induction in a lifetime. Patients with Philadelphia chromosome positive disease must have previously received a tyrosine kinase inhibitor.Patients who achieve a complete response after induction can receive up to three additional cycles for consolidation in a lifetime.Complete response is defined as a patient who:a) has 5% or less bone marrow blasts; andb) has no evidence of disease; andc) has platelet count of more than 50,000 per microlitre; andd) has absolute neutrophil count of more than 500 per microlitre."
"Boric Acid, Resorcinol & Phenol ",Paint,Boric Acid 0.8% + Resorcinol 8% + Phenol 4%,SDL,
Bortezomib,Injection,3.5 mg,MAF,"Checklist to be completed.
           For primary induction in newly diagnosed patients with symptomatic multiple myeloma"
Botulinum toxin type A complex (Botox),Injection,"50 units, 100 units",MAF,"1) For adults with focal spasticity of the upper limbs due to stroke, who have Modified Ashworth Scale of 2 or more at the target muscle intended for botulinum toxin A treatment, and do not have the affected joint permanently fixed in position due
          to fibrotic shortening of the target muscle and are concurrently receiving physiotherapy2) For adults with cervical dystonia, blepharospasm or hemifacial spasm3) For children aged 2 years or older, with focal spasticity of the upper or lower limbs (including dynamic equinus foot deformity) due to cerebral palsy, and who do not have significant joint contractures (i.e. the affected joint is not permanently fixed in position due to shortening of the target muscle); and are concurrently receiving supportive therapy (e.g. physiotherapy or occupational therapy)"
Brimonidine Tartrate,Eye drops,0.15%,SDL,
Bromocriptine,Tablet,2.5 mg,SDL,
Buclizine Hydrochloride ,Tablet,25 mg,SDL,
Budesonide ,Powder inhaler,"100 mcg/dose, 200 mcg/dose",SDL,
Bupivacaine Hydrochloride (hyperbaric) ,Injection,0.5% (in dextrose 8%),SDL,
Bupivacaine Hydrochloride (isobaric),Injection,0.5%,SDL,
Buprenorphine,Sublingual tablet,0.2 mg,SDL,
Busulfan,Injection,60 mg,SDL,
Busulfan,Tablet,2 mg,SDL,
C1 Esterase Inhibitor (Human),Injection,500 international units/10 mL,MAF,Treatment of hereditary angioedema
Cabergoline,Tablet,0.5 mg,MAF,As a 2nd line agent for the management of hyperprolactinaemia in patients who have failed to respond or who are unable to tolerate bromocriptine
Calamine,Lotion,Calamine 15%,SDL,
Calamine & Menthol,Lotion,Calamine 15% + Menthol 0.4%,SDL,
Calcipotriol ,Ointment,50 mcg/g,SDL,
Calcipotriol ,Scalp solution,50 mcg/mL,SDL,
Calcipotriol & Betamethasone ,Gel,Calcipotriol 50 mcg/g + Betamethasone (as Diproprionate) 0.5 mg/g,SDL,
Calcipotriol & Betamethasone ,Ointment,Calcipotriol 50 mcg/g + Betamethasone (as Diproprionate) 0.5 mg/g,SDL,
Calcitriol,Capsule,"0.25 mcg, 0.5 mcg",SDL,
Calcium ,Syrup,20 mg to 23 mg Ca2+/mL,SDL,
Calcium Acetate,Tablet,667 mg,SDL,
Calcium Carbonate,Chewable tablet,1.25 g,SDL,
Calcium Carbonate,Tablet,625 mg,SDL,
Calcium Carbonate & Colecalciferol ,Tablet,Calcium Carbonate 450 mg + Colecalciferol 5 mcg,SDL,
Calcium Chloride Dihydrate ,Injection,10%,SDL,
Calcium Gluconate,Injection,10%,SDL,
Calf Blood Extract (deproteinised) ,Eye gel,8.3 mg/g,SDL,
Calfactant,Intratracheal suspension,"105 mg/3 mL, 210 mg/6 mL  ",SDL, 
Candesartan Cilexetil ,Tablet,"4 mg, 8 mg, 16 mg",MAF,Treatment of patients with heart failure who cannot tolerate angiotensin converting enzyme inhibitors
Capecitabine,Tablet,"150 mg, 500 mg",SDL,
Captopril,Tablet,"12.5 mg, 25 mg",SDL,
Carbamazepine,Controlled-release tablet,"200 mg, 400 mg",SDL,
Carbamazepine,Syrup,100 mg/5 mL,SDL,
Carbamazepine,Tablet,200 mg,SDL,
Carbimazole,Tablet,5 mg,SDL,
Carboplatin,Injection,"150 mg/mL, 10 mg/mL",SDL,
Carmustine,Injection,100 mg,SDL,
Carvedilol,Tablet,"6.25 mg, 12.5 mg, 25 mg",SDL,
Cefalexin ,Capsule,250 mg,SDL,
Cefalexin ,Oral suspension,125 mg/5 mL,SDL,
Cefazolin,Injection,1 g,SDL,
Ceftazidime ,Injection,1 g,SDL,
Ceftriaxone ,Injection,"250 mg, 1 g, 2 g",SDL,
Celecoxib,Capsule,200 mg,SDL, 
Cetirizine,Solution,1 mg/mL,SDL,
Cetrimide,Topical solution,1%,SDL,
Cetrimide,Shampoo,5%,SDL,
Charcoal (activated),Capsule,200 mg,SDL, 
Charcoal (activated),Granules,50 g,SDL,
Charcoal (activated),Oral suspension,200 mg/mL (in sorbitol 70%),SDL,
Charcoal (activated),Tablet,"200 mg, 250 mg",SDL,
Chloral Hydrate,Oral solution,"200 mg/5 mL, 500 mg/5 mL",SDL,
Chlorambucil,Tablet,2 mg,SDL,
Chloramphenicol,Eye drops,0.5%,SDL,
Chloramphenicol,Eye ointment,1%,SDL,
Chlordiazepoxide,Tablet,5 mg,SDL,
Chlorhexidine Gluconate ,Cream,1%,SDL,
Chlorhexidine Salt ,Mouthwash,0.2%,SDL,
Chlorhexidine Salt ,Topical solution," 0.05%, 0.1% ",SDL,
Chlorhexidine Salt ,Topical solution,4%,SDL,
Chlorhexidine Salt ,Mouthwash,0.2%,SDL,
Chlorhexidine Salt & Alcohol,Topical solution,"Chlorhexidine Salt 0.1% + Alcohol 70%, Chlorhexidine Salt 0.5% + Alcohol 70%",SDL,
Chlorhexidine Salt & Cetrimide,Topical solution,Chlorhexidine Salt 0.015% + Cetrimide 0.15%,SDL,
Chloroquine Phosphate,Tablet,150 mg,SDL,
Chlorpheniramine,Syrup,4 mg/5 mL,SDL,
Chlorpheniramine,Tablet,4 mg,SDL,
Chlorpromazine,Injection,50 mg/2 mL,SDL,
Chlorpromazine,Tablet,"25 mg, 100 mg",SDL,
Chlorpropamide,Tablet,250 mg,SDL,
Chlortetracycline,Eye ointment,1%,SDL,
Choline Salicylate & Cetylpyridinium Chloride,Oral gel,Choline Salicylate 8.7% + Cetylpyridinium Chloride 0.01%,SDL,
Ciclosporin,Capsule,"10 mg, 25 mg, 100 mg",SDL,
Ciclosporin,Concentrate for infusion,50 mg/mL,SDL, 
Ciclosporin,Oral solution,100 mg/mL,SDL, 
Cimetidine,Injection,"200 mg/2 mL, 150 mg/mL",SDL,
Cimetidine,Tablet,200 mg,SDL,
Ciprofloxacin,Tablet,"250 mg, 500 mg",SDL,
Ciprofloxacin,Eye/ear drops,0.3%,SDL,
Ciprofloxacin ,Infusion,2 mg/mL,SDL,
Cisplatin,Concentrate for infusion,50 mg/50 mL,SDL,
Citric Acid Monohydrate & Potassium Citrate ,Oral solution,Citric Acid Monohydrate 0.25 g/5 mL + Potassium Citrate 1.5 g/5 mL,SDL,
Clarithromycin,Modified-release tablet,500 mg,SDL,
Clarithromycin,Tablet,"250 mg, 500 mg",SDL,
Clarithromycin ,Injection,500 mg,SDL,
Clarithromycin ,Oral suspension,125 mg/5 mL,SDL,
Clidinium & Chlordiazepoxide,Tablet,Clidinium Bromide 2.5 mg + Chlordiazepoxide 5 mg,SDL,
Clindamycin ,Capsule,150 mg,SDL,
Clindamycin ,Injection,150 mg/mL,SDL,
Clobetasol propionate,Cream,0.05%,SDL, 
Clobetasol propionate,Ointment,0.05%,SDL, 
Clomiphene,Tablet,50 mg,SDL,
Clomipramine,Tablet,25 mg,SDL,
Clonazepam,Tablet,"0.5 mg, 2 mg",SDL,
Clopidogrel,Tablet,75 mg,SDL,
Clotrimazole,Cream,1%,SDL,
Clotrimazole,Lotion,1%,SDL,
Clotrimazole,Powder,1%,SDL,
Clotrimazole,Vaginal tablet,100 mg,SDL,
Cloxacillin,Capsule,250 mg,SDL,
Cloxacillin,Injection,"250 mg, 500 mg",SDL,
Cloxacillin,Syrup,125 mg/5 mL,SDL,
Clozapine,Tablet,"25 mg, 100 mg",SDL,
Coal Tar,Cream,"5%, 10%, 15%",SDL,
Coal Tar,Lotion,20%,SDL,
Coal Tar,Shampoo,25%,SDL,
Coal Tar & Salicylic Acid,Ointment,Coal Tar 5% + Salicylic acid 2%,SDL,
Cocaine,Solution ,10%,SDL,
Cocois Compound,Ointment,Coal Tar Solution 10% + Camphor 2% + Sulphur 4% + Salicylic Acid 2%,SDL,
Codeine & Promethazine,Syrup,Codeine Phosphate 18 mg/10 mL + Promethazine 7.2 mg/10 mL,SDL,
Codeine Phosphate,Tablet,30 mg,SDL,
Coenzyme Q10,Capsule,50 mg,MAF,Treatment of mitochondrial disorders
Colchicine,Tablet,500 mcg,SDL,
Colecalciferol,Tablet,"1,000 units",SDL,
Colestyramine,Powder for oral suspension,4 g,SDL,
Compound Diphenhydramine,Syrup,Ranging from 5 mg/5 mL to 14 mg/5 mL,SDL,
Compound Polyethylene Glycol (Fortrans),Oral powder,-,SDL,
Compound Sodium Lactate ,Infusion,-,SDL,
Conjugated Oestrogens,Tablet,"0.3 mg, 0.625 mg",SDL,
Conjugated Oestrogens,Vaginal cream,0.625 mg/g,SDL,
Cyanocobalamin,Injection,1 mg/mL,SDL,
Cyclophosphamide,Infusion,"200 mg, 1 g",SDL,
Cyclophosphamide,Tablet,50 mg,SDL,
Cyproheptadine,Tablet,4 mg,SDL,
Cytarabine,Injection,"20 mg/mL, 100 mg/mL",SDL,
Dacarbazine,Injection,200 mg,SDL,
Dactinomycin,Infusion,500 mcg,SDL,
Dantrolene Sodium ,Capsule,"25 mg, 100 mg",SDL,
Dapagliflozin,Tablet,"5 mg, 10 mg",MAF,"1) Treatment of type 2 diabetes mellitus, as a dual therapy
          • In combination with metformin for patients with HbA1c > 7% despite treatment with metformin monotherapy;
          • In combination with a sulfonylurea for patients with HbA1c > 7% despite treatment with sulfonylurea monotherapy and when metformin is contraindicated or not tolerated;
           2) Treatment of type 2 diabetes mellitus as a triple therapy
          • In combination with metformin and a sulfonylurea for patients with HbA1c > 7% despite treatment with optimal doses of dual therapy
           3) Treatment of type 2 diabetes mellitus in combination with insulin, with or without metformin"
Dapsone,Tablet,100 mg,SDL,
Darunavir,Tablet,"600 mg, 800 mg ",SDL, 
Daunorubicin,Injection,20 mg,SDL,
Deferasirox,Tablet,"90 mg, 360 mg",SDL, 
Deferiprone ,Oral solution,100 mg/mL,SDL,
Deferiprone ,Tablet,500 mg,SDL,
Deferoxamine Mesilate ,Injection,500 mg,SDL,
Denosumab,Prefilled syringe,60 mg/mL,MAF,Treatment of post-menopausal women with osteoporosis (T-score ≤ -2.5) at high risk of fracture and eGFR > 30 mL/min and who are unable to tolerate or follow the administration instructions for oral bisphosphonates
Dequalinium Chloride ,Lozenge,0.25 mg,SDL,
Desmopressin Acetate ,Nasal drops,0.1 mg/mL,SDL,
Desmopressin Acetate ,Nasal spray,10 mcg/dose,SDL,
Desmopressin Acetate ,Tablet,"0.1 mg, 0.2 mg",SDL,
Dexamethasone,Tablet,"500 mcg, 4 mg",SDL,
Dexamethasone Phosphate ,Injection,4 mg/mL,SDL,
Dexmedetomidine ,Concentrate for infusion,200 mcg/2 mL,SDL,
Dextromethorphan Hydrobromide ,Syrup,15 mg/5 mL,SDL,
Dextromethorphan Hydrobromide ,Tablet,15 mg,SDL,
Dextrose & Potassium Chloride,Infusion,Dextrose 5% + Potassium Chloride 0.15%,SDL,
Dextrose & Sodium Chloride,Infusion,"Dextrose 2.5% + Sodium Chloride 0.45%, Dextrose 5% + Sodium Chloride 0.2%, Dextrose 5% + Sodium Chloride 0.45%, Dextrose 5% + Sodium Chloride 0.9% ",SDL,
Dextrose Monohydrate ,Infusion,"5%, 10%, 20%, 50%",SDL,
Dextrose Monohydrate,Injection,50%,SDL, 
"Dextrose, Potassium Chloride & Sodium Chloride",Infusion,"Dextrose 5% + Potassium Chloride 0.15% + Sodium Chloride 0.33%, Dextrose 5% + Potassium Chloride 0.22% + Sodium Chloride 0.45%, Dextrose 5% + Potassium Chloride 0.30% + Sodium Chloride 0.45%, Dextrose 5% + Potassium Chloride 0.15% + Sodium Chloride 0.45%, Dextrose 5% + Potassium Chloride 0.15% + Sodium Chloride 0.9%",SDL,
Diazepam,Enema,5 mg/2.5 mL,SDL,
Diazepam,Injection,5 mg/mL,SDL,
Diazepam,Tablet,"2 mg, 5 mg, 10 mg",SDL,
Dibasic Sodium Phosphate & Monobasic Sodium Phosphate,Enema,"Dibasic Sodium Phosphate 7 g/118 mL + Monobasic Sodium Phosphate 19 g/118 mL, Dibasic Sodium Phosphate 3.5 g/59 mL + Monobasic Sodium Phosphate 9.5 g/59 mL",SDL,
Diclofenac Sodium,Enteric-coated tablet,"25 mg, 50 mg",SDL,
Diclofenac Sodium,Injection,25 mg/mL,SDL,
Diclofenac Sodium,Rectal suppository,"12.5 mg, 25 mg, 50 mg",SDL,
Diclofenac Sodium,Gel,1%,SDL,
Diethylcarbamazine Citrate ,Tablet,50 mg,SDL,
Digoxin,Injection,"100 mcg/mL, 250 mcg/mL",SDL,
Digoxin,Oral solution,50 mcg/mL,SDL,
Digoxin,Tablet,"62.5 mcg, 250 mcg",SDL,
Digoxin-specific Antibody Fragments ,Injection,40 mg,SDL,
Diltiazem Hydrochloride ,Injection,"10 mg, 50 mg",SDL,
Diltiazem Hydrochloride ,Sustained-release capsule,"90 mg, 100 mg, 200 mg",SDL,
Diltiazem Hydrochloride ,Tablet,"30 mg, 60 mg",SDL,
Dimercaprol,Injection,50 mg/mL,SDL,
Diosmin & Hesperidin,Tablet,Diosmin 450 mg + Hesperidin 50 mg,SDL,
Diphenoxylate & Atropine Sulfate,Tablet,Diphenoxylate Hydrochloride 2.5 mg + Atropine Sulfate 25 mcg,SDL,
Diphtheria & Tetanus Vaccine,Injection,Diphtheria Toxoid Vaccine minimum 2 international units/0.5 mL + Tetanus Toxoid Vaccine minimum 20 international units/0.5 mL,SDL,
Diphtheria Antitoxin,Injection,"10,000 units",SDL,
Dipyridamole,Tablet,"25 mg, 75 mg",SDL,
Disodium Edetate,Eye drops,"0.38%, 3%",SDL,
Dobutamine,Concentrate for infusion,"250 mg/5 mL, 250 mg/20 mL",SDL,
Docetaxel,Infusion,"20 mg, 80 mg, 160 mg",SDL, 
Donepezil Hydrochloride,Oral disintegrating tablet,"5 mg, 10 mg",MAF,For patients with mild to moderately severe Alzheimer's Disease who have swallowing difficulties and are unable to receive a film-coated tablet
Donepezil Hydrochloride,Tablet,"5 mg, 10 mg",SDL,
Dopamine Hydrochloride ,Concentrate for infusion,200 mg/5 mL,SDL,
Dolutegravir,Tablet,50 mg,SDL, 
Dothiepin Hydrochloride ,Capsule,25 mg,SDL,
Doxorubicin Hydrochloride ,Injection,"10 mg, 50 mg",SDL,
Doxycycline,Capsule,100 mg,SDL,
Droperidol,Injection,2.5 mg/mL,SDL,
Dutasteride,Capsule,0.5 mg,SDL, 
Dydrogesterone,Tablet,10 mg,SDL,
Efavirenz,Tablet,"200 mg, 600 mg",SDL, 
Empagliflozin, Tablet," 10 mg, 25 mg", MAF,"1) Treatment of type 2 diabetes mellitus, as a dual therapy• In combination with metformin for patients with HbA1c > 7% despite treatment with metformin monotherapy;• In combination with a sulfonylurea for patients with HbA1c > 7% despite treatment with sulfonylurea monotherapy and when metformin is contraindicated or not tolerated;2) Treatment of type 2 diabetes mellitus as a triple therapy• In combination with metformin and a sulfonylurea for patients with HbA1c > 7% despite treatment with optimal doses of dual therapy3) Treatment of type 2 diabetes mellitus in combination with insulin, with or without metformin"
Emtricitabine & Tenofovir Disoproxil Fumarate,Tablet,Emtricitabine 200 mg + tenofovir disoproxil fumarate 300 mg,MAF,In combination with other antiretroviral agents for the treatment of HIV-1 infection
Emulsifying Ointment,Ointment,-,SDL,
Enalapril Maleate ,Tablet,"5 mg, 10 mg, 20 mg",SDL,
Enoxaparin Sodium ,Injection,"20 mg/0.2 mL, 40 mg/0.4 mL, 60 mg/0.6 mL, 80 mg/0.8 mL",SDL,
Entacapone,Tablet,200 mg,SDL,
Entecavir,Tablet,0.5 mg,SDL, 
Entecavir ,Tablet,1 mg,MAF,"Treatment of nucleos(t)ide-naïve patients with HBeAg-positive and HBeAg-negative chronic hepatitis B infection and evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically
          active disease"
Ephedrine Sulfate ,Injection,30 mg/mL,SDL,
Epoetin Alfa,Injection ,"2,000 international units/0.5 mL, 4,000 international units/0.4 mL",SDL,
Epoetin Beta,Injection,"2,000 international units/0.3 mL, 4,000 international units/0.3 mL",SDL,
Epoprostenol (Veletri),Infusion,1.5 mg,MAF,Treatment of pulmonary arterial hypertension (idiopathic or heritable PAH or PAH associated with connective tissue diseases) in patients with WHO Functional Class III-IV symptoms
Eptifibatide,Injection,20 mg/10 mL,SDL, 
Eptifibatide,Infusion,75 mg/100 mL,SDL, 
Ergometrine Maleate ,Injection,500 mcg/mL,SDL,
Ergotamine & Caffeine,Tablet,Caffeine 100 mg + Ergotamine Tartrate 1 mg,SDL,
Erythromycin (as Ethyl Succinate),Tablet,400 mg,SDL,
Erythromycin (as Ethyl Succinate) ,Oral suspension,200 mg/5 mL,SDL,
Erythromycin (as Lactobionate) ,Infusion,"500 mg, 1 g",SDL,
Erythromycin Stearate,Enteric-coated tablet,250 mg ,SDL,
Estradiol,Vaginal tablet,10 mcg,SDL,
Etanercept,Prefilled syringe,"25 mg/0.5 mL, 50 mg/mL",MAF,Checklist to be completed1) Treatment of adult patients with non-radiographic axial spondyloarthritis2) Treatment of juvenile idiopathic arthritis3) Treatment of adult patients with chronic plaque psoriasis
Etanercept,Injection,25 mg/mL,MAF,Checklist to be completed1) Treatment of adult patients with non-radiographic axial spondyloarthritis2) Treatment of juvenile idiopathic arthritis3) Treatment of adult patients with chronic plaque psoriasis
Ethambutol Hydrochloride ,Tablet,"100 mg, 400 mg",SDL,
Ethanol,Solution,Minimum 95%,SDL,
Ethionamide,Tablet,250 mg,SDL,
Ethyl Chloride,Topical spray,88 g/100 mL,SDL,
Etoposide,Capsule,50 mg,SDL,
Etoposide,Concentrate for infusion,20 mg/mL,SDL,
Etoricoxib,Tablet,"60 mg, 90 mg, 120 mg",SDL, 
Etravirine,Tablet,200 mg,SDL , 
Everolimus,Tablet,"0.25 mg, 0.75 mg",SDL , 
Ezetimibe,Tablet,10 mg,SDL,
Factor Eight Inhibitor Bypassing Activity (FEIBA),Injection,500 units,SDL, 
Famotidine,Tablet,20 mg,SDL,
Fenofibrate,Capsule,"100 mg, 300 mg",SDL,
Fentanyl,Injection,50 mcg/mL,SDL,
Fentanyl,Transdermal patch,"12 mcg/hr, 25 mcg/hr, 50 mcg/hr",SDL,
Ferric Carboxymaltose,Injection,500 mg/10 mL,SDL, 
Ferrous Fumarate,Tablet,200 mg,SDL,
Ferrous Gluconate,Tablet,300 mg,SDL,
"Ferrous Gluconate, Multivitamins & Minerals ",Capsule,Ferrous Gluconate 250 mg + Vit B12 7.5 mcg + Vit C 50 mg + Folic Acid 1 mg + Sorbitol 25 mg + Copper Sulfate 200 mcg + Manganese Sulfate 200 mcg,SDL,
Ferrous Sulphate & Vitamin B1 & Riboflavin & Nicotinamide,Tablet,Ferrous Sulphate 200 mg + Vitamin B1 3 mg + Riboflavin 1.5 mg + Nicotinamide 10 mg,SDL,
Fexofenadine,Oral suspension,6 mg/mL,SDL, 
Filgrastim,Injection,"30 million units/0.5 mL (300 mcg/0.5 mL), 30 million units/mL (300 mcg/mL)",SDL,
Finasteride ,Tablet,5 mg,SDL,
Flecainide Acetate,Tablet,100 mg,SDL, 
Fluconazole,Capsule,"50 mg, 100 mg, 150 mg",SDL,
Fluconazole,Infusion,100 mg/50 mL,SDL,
Fludrocortisone Acetate ,Tablet,0.1 mg,SDL,
Flumazenil,Injection,0.1 mg/mL,SDL,
Fluocinolone Acetonide,Cream,"0.003125%, 0.00625%, 0.0125%, 0.025%",SDL,
Fluorescein Sodium,Injection,10%,SDL,
Fluorescein Sodium,Single-use eye drops,2%,SDL,
Fluorouracil,Injection,50 mg/mL,SDL,
Fluoxetine,Capsule,"10 mg, 20 mg",SDL,
Flupenthixol Decanoate,Injection,"20 mg/mL, 40 mg/2 mL",SDL,
Fluphenazine Decanoate,Injection,25 mg/mL,SDL,
Fluticasone Propionate,Inhaler,"50 mcg/dose, 125 mcg/dose, 250 mcg/dose",SDL,
Fluvoxamine Maleate,Tablet,50 mg,SDL,
Folic Acid,Tablet,5 mg,SDL,
Folinic Acid,Injection,10 mg/mL,SDL,
Formoterol & Budesonide,Inhaler,"Formoterol Fumarate Dihydrate 2.25 mcg/dose + Budesonide 80 mcg/dose (120 doses), Formoterol Fumarate Dihydrate 4.5 mcg/dose + Budesonide 80 mcg/dose (120 doses), Formoterol Fumarate Dihydrate 4.5 mcg/dose + Budesonide 160 mcg/dose (120 doses)",SDL, 
Formoterol & Budesonide,Powder inhaler,"Formoterol Fumarate Dihydrate 4.5 mcg/dose + Budesonide 80 mcg/dose (60 doses), Formoterol Fumarate Dihydrate 4.5 mcg/dose + Budesonide 160 mcg/dose (120 doses), Formoterol Fumarate Dihydrate 9 mcg/dose + Budesonide 320 mcg/dose (60 doses)",SDL,
Furosemide ,Injection,10 mg/mL,SDL,
Furosemide ,Tablet,40 mg,SDL,
Gabapentin,Capsule,"100 mg, 300 mg, 400 mg",SDL,
Ganciclovir,Infusion,500 mg,SDL,
Gelatin Succinylated & Sodium Chloride ,Infusion,Gelatin Succinylated 4 g/100 mL + Sodium Chloride 0.701 g/100 mL,SDL,
Gemcitabine,Infusion,"200 mg, 1000 mg, 2000 mg",SDL,
Gemfibrozil,Capsule,300 mg,SDL,
Gentamicin,Injection,40 mg/mL,SDL,
Gentamicin,Eye drops,0.3%,SDL,
Gentian Violet,Paint,0.5%,SDL,
Glecaprevir & Pibrentasvir,Tablet,Glecaprevir 100 mg + pibrentasvir 40 mg tablet,MAF,"Treatment of chronic hepatitis C (all genotypes) infection in treatment-naïve, pegylated interferon plus ribavirin (with or without sofosbuvir)-experienced and sofosbuvir plus ribavirin-experienced adults.Glecaprevir/Pibrentasvir should be used in line with the recommended treatment regimen and duration:Treatment-naive• 8 weeks’ treatment of glecaprevir/pibrentasvir for patients with hepatitis C virus (all genotypes) without cirrhosis or compensated cirrhosis (Child-Pugh A);Treatment-experienced• 8 weeks’ treatment of glecaprevir/pibrentasvir for patients with hepatitis C virus (genotypes 1,2,4,5,6) without cirrhosis• 12 weeks’ treatment of glecaprevir/pibrentasvir for patients with hepatitis C virus (genotypes 1,2,4,5,6) with compensated cirrhosis (Child-Pugh A)• 16 weeks’ treatment of glecaprevir/pibrentasvir for patients with hepatitis C virus (genotype 3) without cirrhosis or with compensated cirrhosis (Child-Pugh A)"
Glibenclamide,Tablet,5 mg,SDL,
Gliclazide,Tablet,80 mg,SDL,
Glipizide,Tablet,5 mg,SDL,
Glucagon,Injection,1 mg,SDL,
Glycerol,Rectal suppository,"1 g, 1.5 g, 2 g",SDL,
"Glycerol, Methyl Salicylate, Sodium Salicylate & Thymol Compound",Mouthwash,Glycerol 10% + Methyl Salicylate 0.03% + Sodium Salicylate 0.52% + Thymol 0.05%,SDL,
Glyceryl Trinitrate,Oral spray,0.4 mg/dose,SDL,
Glyceryl Trinitrate,Patch,"5 mg, 10 mg",SDL,
Glyceryl Trinitrate,Sublingual tablet,0.5 mg,SDL,
Glycine,Irrigation solution,1.5%,SDL,
Golimumab,Prefilled syringe,"50 mg/0.5 mL, 100 mg/mL",MAF,"Checklist to be completed
           1) Treatment of adult patients with rheumatoid arthritis
           2) Treatment of adult patients with ankylosing spondylitis
           3) Treatment of adult patients with psoriatic arthritis
           4) Treatment of adult patients with non-radiographic axial spondyloarthritis
           5) Treatment of adult patients with ulcerative colitis"
Goserelin ,Subcutaneous injectable implant,"3.6 mg, 10.8 mg",MAF,"LHRH agonist is recommended:
           1) As primary therapy for men with locally advanced or metastatic prostate cancer
           2) As neoadjuvant therapy, for 3 months to 2 years, in men receiving radical radiotherapy
           3) For men with prostate cancer who have a biochemical relapse
           LHRH agonist is not recommended as monotherapy in patients with low risk prostate cancer"
Griseofulvin,Tablet,"125 mg, 500 mg",SDL,
Guaifenesin ,Syrup,100 mg/5 mL,SDL,
Haemodialysis Concentrate 35X (Acetate Salt),Solution,"The diluted solution contains: Na+ 140.0 mmol/L, K+ 2.60 mmol/L, Ca2+ 1.38 mmol/L, Mg2+ 0.62 mmol/L, Cl- 102 mmol/L, HCO3- 45 mmol/L",SDL,
Haemodialysis Concentrate 35X (Bicarbonate),Solution (comprised 2 separate 10 L canisters: acidic & basic),"Acidic concentrate: KCl 5.5 g/L, NaCl 161.0 g/L, CaCl2.2H2O 9.7 g/L, MgCl2.6H2O 3.7 g/L, CH3COOH (glacial) 8.8 g/L; Basic concentrate: NaCl 30.5 g/L, HCO3- 66.0 g/L; Final diluted solution contains: Na+ 140 mmol/L, K+ 2.0 mmol/L, Ca2+ 1.8 mmol/L,
          Mg2+ 0.5 mmol/L, Cl- 107.2 mmol/L, CH3COO- 4.0 mmol/L, HCO3- 35.0 mmol/L",SDL,
Haloperidol,Injection,5 mg/mL,SDL,
Haloperidol,Oral solution,2 mg/mL,SDL,
Haloperidol,Tablet,"0.5 mg, 1.5 mg, 5 mg",SDL,
Heparin Sodium ,Injection,"1,000 units/mL, 5,000 units/mL, 25,000 units/5 mL",SDL,
Heparinised Saline,"Injection (in sodium chloride 0.9%, preservative-free)",50 international units/5 mL,SDL,
Hepatitis B Immunoglobulin,Injection,"≥ 200 international units/mL (adults), ≥100 international units/mL (children)",SDL,
Homatropine Hydrobromide ,Eye drops,2%,SDL,
Human Hemin,Infusion,250 mg/10 mL,MAF,"Treatment of acute attacks of hepatic porphyria (acute intermittent porphyria, porphyria variegata, hereditary coproporphyria)"
Hydralazine Hydrochloride,Tablet,"10 mg, 25 mg, 50 mg",SDL,
Hydralazine Hydrochloride ,Injection,20 mg/mL,SDL,
Hydrochlorothiazide,Tablet,25 mg,SDL,
Hydrocolloid (carboxymethylcellulose-containing),Dressing,-,SDL,
Hydrocolloid (carboxymethylcellulose-containing),Gel,-,SDL,
Hydrocortisone,Cream,"0.5%, 1%",SDL,
Hydrocortisone,Ointment,1%,SDL,
Hydrocortisone,Tablet,10 mg,SDL,
Hydrocortisone (as Sodium Succinate),Injection,100 mg,SDL,
Hydrocortisone Acetate,Rectal foam,10%,SDL,
Hydrocortisone Acetate & Clioquinol,Cream,Hydrocortisone Acetate 1% + Clioquinol 3%,SDL,
Hydrogen Peroxide,Mouthwash,3%,SDL,
Hydrogen Peroxide,Topical solution,3%,SDL,
Hydroxocobalamin,Injection,1 mg/mL,MAF,Treatment of cobalamin-related remethylation pathway defect causing cobalamin C deficiency
Hydroxychloroquine Sulphate,Tablet,200 mg,SDL,
Hydroxychloroquine Sulphate ,Tablet,200 mg,SDL,
Hydroxyprogesterone Caporate,Injection,250 mg/mL,SDL,
Hydroxyurea,Capsule,500 mg,SDL,
Hydroxyzine Hydrochloride,Tablet,"10 mg, 25 mg",SDL,
Hydroxyzine Hydrochloride ,Syrup,10 mg/5 mL,SDL,
Hyoscine Butylbromide,Injection,20 mg/mL,SDL,
Hyoscine Butylbromide,Tablet,10 mg,SDL,
Hyoscine Hydrobromide Trihydrate,Injection,400 mcg/mL,SDL,
Hypromellose,Eye drops,0.3%,SDL,
Ibuprofen,Oral liquid,100 mg/5 mL,SDL,
Ibuprofen,Tablet,200 mg,SDL,
Ifosfamide,Infusion,1 g,SDL,
Imatinib (Generic)*,Capsule,"100 mg, 400 mg",SDL,*Generic formulation cannot be used for gastrointestinal stromal tumours (GIST) due to patent protection
Imatinib (Generic)*,Tablet,"100 mg, 400 mg",SDL,*Generic formulation cannot be used for gastrointestinal stromal tumours (GIST) due to patent protection
Imipenem & Cilastatin ,Infusion,Imipenem 500 mg + Cilastatin 500 mg,SDL,
Imipramine Hydrochloride ,Tablet,"10 mg, 25 mg",SDL,
Indometacin,Capsule,25 mg,SDL,
Infliximab (Remsima) ,Infusion,100 mg,SDL, 
Insulin Aspart,"Injection, penfill",100 international units/mL,MAF,Type 1 & 2 diabetes mellitus
Insulin Aspart,"Injection, prefilled pen",100 international units/mL,SDL,
Insulin Aspart & Insulin Aspart Protamine,"Injection, prefilled pen",Insulin Aspart 30% + Insulin Aspart Protamine 70%,SDL,
Insulin Detemir,"Injection, prefilled pen",100 international units/mL,SDL,
Insulin Glargine (Basaglar),"Injection, cartridge",100 international units/mL,SDL,
Insulin Glargine (Lantus),Injection,100 international units/mL,SDL,
Insulin Glargine (Lantus),"Injection, prefilled pen",100 international units/mL,SDL,
Insulin Glulisine,"Injection, prefilled pen",100 international units/mL,SDL,
Insulin Isophane (Human),Injection,100 international units/mL,SDL,
Insulin Isophane (Human),"Injection, penfill",100 international units/mL,SDL,
Insulin Lispro,Injection,100 international units/mL,MAF,Type 1 & 2 diabetes mellitus
Insulin Lispro,"Injection, prefilled pen",100 international units/mL,MAF,Type 1 & 2 diabetes mellitus
Insulin Lispro & Insulin Lispro Protamine,"Injection, penfill",Insulin Lispro 25% + Insulin Lispro Protamine 75% ,SDL,
Insulin Lispro & Insulin Lispro Protamine,"Injection, prefilled pen",Insulin Lispro 25% + Insulin Lispro Protamine 75% ,MAF,Type 1 & 2 diabetes mellitus
Insulin Lispro & Insulin Lispro Protamine,"Injection, prefilled pen",Insulin Lispro 50% + Insulin Lispro Protamine 50% ,MAF,Type 1 & 2 diabetes mellitus
Insulin Soluble & Insulin Isophane (Human),Injection,Insulin Soluble 30% + Insulin Isophane 70%,SDL,
Insulin Soluble & Insulin Isophane (Human),"Injection, penfill",Insulin Soluble 30% + Insulin Isophane 70%,SDL,
Insulin Soluble (Human),Injection,100 international units/mL,SDL,
Insulin Soluble (Human),"Injection, penfill",100 international units/mL,SDL,
Interferon Alfa-2a,Injection,3 million international units/0.5 mL,SDL,
Intraperitoneal Dialysis,Solution,"Dextrose 1.5%, 2.5% or 4.25% with Ca2+ 1.25 mmol/L, Na+ 132 mmol/L, Mg2+ 0.25 mmol/L, Cl- 95 mmol/L, Lactate 40 mmol/L; Dextrose 1.5%, 2.5% or 4.25% with Ca2+ 2.57 mmol/L, Na+ 132 mmol/L, Mg2+ 0.25 mmol/L, Cl- 96 mmol/L, Lactate 40 mmol/L",SDL,
Iodine,Topical solution,"0.5%, 1.0%, 2.5%",SDL,
Iodine Aqueous ,Oral solution,Iodine 5% + Potassium iodide 10% ,SDL,
Ipratropium Bromide ,Inhaler,20 mcg/dose,SDL,
Ipratropium Bromide ,Nebulisation solution,0.025%,SDL,
Irinotecan Hydrochloride Trihydrate,Infusion,20 mg/mL,SDL,
Iron (as Polymaltose) ,Oral drops,50 mg/mL,SDL,
Iron (as Polymaltose),Tablet,100 mg,SDL , 
Iron (as Sucrose) ,Injection,100 mg/5 mL,SDL,
Isoniazid,Tablet,"100 mg, 300 mg",SDL,
Isoprenaline Hydrochloride,Injection,"0.2 mg/mL, 1 mg/mL",SDL,
Isoprenaline Sulfate,Injection,"0.2 mg/mL, 1 mg/mL",SDL,
Isosorbide Dinitrate,Tablet,10 mg,SDL,
Isosorbide Mononitrate,Sustained-release tablet,60 mg,SDL,
Itraconazole,Capsule,100 mg,SDL,
Itraconazole,Oral solution,10 mg/mL,MAF,For prophylaxis of invasive fungal infections in high risk patients (such as anticipated to have prolonged neutropenia) and haematopoietic stem cell transplant recipients
Ivabradine,Tablet,"5 mg, 7.5 mg",MAF,"Treatment of chronic heart failure in patients with New York Heart Association (NYHA) class II to IV stable chronic heart failure with systolic dysfunction (LVEF of 35% or less), and who are in sinus rhythm with a heart rate of 75 bpm or more,
          and who are given concomitant standard medical management including the maximum tolerated dose of beta-blocker therapy, angiotensin converting enzyme inhibitors and aldosterone antagonists, unless contraindicated or not tolerated"
Ixekizumab,"Injection, prefilled pen",80 mg/mL,MAF,Checklist to be completed1) Treatment of adult patients with psoriatic arthritis2) Treatment of adult patients with chronic plaque psoriasis
Kanamycin,Injection,1 g,SDL,
"Kaolin, Magnesium Carbonate (light) & Sodium Bicarbonate ",Oral suspension,Kaolin 20% + Magnesium Carbonate (light) 5% + Sodium Bicarbonate 5%,SDL,
Ketoprofen,Enteric-coated tablet,100 mg,SDL,
Ketoprofen,Gel,2.5%,SDL,
L-Arginine,Capsule,500 mg,MAF,"1) Treatment of mitochondrial diseases including MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like episodes)2) Treatment of urea cycle defects"
L-Arginine,Injection,"4.2 g/20 mL, 5 g/10 mL",MAF,"1) Treatment of mitochondrial diseases including MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like episodes)2) Treatment of urea cycle defects"
L-Arginine,Tablet,500 mg,MAF,"1) Treatment of mitochondrial diseases including MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like episodes)2) Treatment of urea cycle defects"
L-Asparaginase,Injection,"10,000 international units",SDL, 
L-Citrulline,Capsule,750 mg,MAF,"1) Treatment of hyperammonemia secondary to urea cycle disorders (proximal urea cycle defect, ornithine transcarbamylase deficiency or carbamoyl phosphate synthetase deficiency).2) Acute treatment of mitochondrial diseases including MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like episodes)"
L-Citrulline,Powder,5 g,MAF,"1) Treatment of hyperammonemia secondary to urea cycle disorders (proximal urea cycle defect, ornithine transcarbamylase deficiency or carbamoyl phosphate synthetase deficiency).2) Acute treatment of mitochondrial diseases including MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like episodes)"
L-Isoleucine,Powder,100 mg/1.5 g,MAF,Treatment of Maple Syrup Urine Disease
L-Valine,Powder ,100 mg/1.5 g,MAF,Treatment of Maple Syrup Urine Disease
Lactulose,Syrup,"3.3 g/5 mL, 3.35 g/5 mL",SDL,
Lamivudine,Tablet ,"100 mg, 150 mg",SDL,
Lamotrigine,Dispersible tablet,5 mg,SDL,
Lamotrigine,Tablet,"50 mg, 100 mg",SDL,
Land Snakes Antivenom ,Concentrate for infusion,-,SDL,
Latanoprost,Eye drops,0.005%,SDL,
Leflunomide ,Tablet,"20 mg, 100 mg",MAF,"1) Treatment of active psoriatic arthritis where other disease modifying drugs are ineffective and/ or inappropriate
           2) Treatment of active rheumatoid arthritis where other disease modifying drugs are ineffective and/ or inappropriate"
Letrozole,Tablet,2.5 mg,SDL,
Leuprorelin Acetate ,Injection,"3.75 mg, 7.5 mg, 11.25 mg, 22.5 mg, 30 mg, 45 mg, 5 mg/mL",MAF,"LHRH agonist is recommended:
           1) As primary therapy for men with locally advanced or metastatic prostate cancer
           2) As neoadjuvant therapy, for 3 months to 2 years, in men receiving radical radiotherapy
           3) For men with prostate cancer who have a biochemical relapse
           LHRH agonist is not recommended as monotherapy in patients with low risk prostate cancer"
Levetiracetam ,Concentrate for infusion,100 mg/mL,MAF,"1) As a 2nd line agent for the management of epilepsy in adults and children
           2) As adjunctive therapy or monotherapy in patients who have inadequate seizure control or intolerable adverse effects with 1st line agents, or where the use of 1st line agents is contraindicated"
Levetiracetam ,Oral solution,100 mg/mL,MAF,"1) As a 2nd line agent for the management of epilepsy in adults and children
           2) As adjunctive therapy or monotherapy in patients who have inadequate seizure control or intolerable adverse effects with 1st line agents, or where the use of 1st line agents is contraindicated"
Levetiracetam ,Tablet,"250 mg, 500 mg, 1 g",MAF,"1) As a 2nd line agent for the management of epilepsy in adults and children
           2) As adjunctive therapy or monotherapy in patients who have inadequate seizure control or intolerable adverse effects with 1st line agents, or where the use of 1st line agents is contraindicated"
Levocarnitine,Capsule,500 mg,MAF,Prevention of primary and secondary carnitine deficiency due to detoxification
Levocarnitine,Injection ,1 g/5 mL,MAF,Prevention of primary and secondary carnitine deficiency due to detoxification
Levocarnitine,Oral solution,500 mg/10 mL,MAF,Prevention of primary and secondary carnitine deficiency due to detoxification
Levodopa & Benserazide,Capsule,Levodopa 100 mg + Benserazide 25 mg,SDL,
Levodopa & Benserazide,Tablet,Levodopa 200 mg + Benserazide 50 mg,SDL,
Levodopa & Benserazide,Controlled-release capsule,Levodopa 100 mg + Benserazide 25 mg,SDL,
Levodopa & Carbidopa,Tablet,"Levodopa 100 mg + Carbidopa 25 mg, Levodopa 250 mg + Carbidopa 25 mg",SDL,
Levodopa & Carbidopa ,Sustained-release tablet,Levodopa 200 mg + Carbidopa 50 mg ,SDL,
"Levodopa, Carbidopa & Entacapone",Tablet,"Levodopa 50 mg + Carbidopa 12.5 mg + Entacapone 200 mg, Levodopa 100 mg + Carbidopa 25 mg + Entacapone 200 mg, Levodopa 150 mg + Carbidopa 37.5 mg + Entacapone 200 mg, Levodopa 200 mg + Carbidopa 50 mg + Entacapone 200 mg",SDL,
Levonorgestrel & Ethinylestradiol,Tablet,Levonorgestrel 0.15 mg + Ethinylestradiol 0.03 mg,SDL,
Levothyroxine Sodium ,Tablet,"25 mcg, 50 mcg, 75 mcg, 100 mcg",SDL,
Lidocaine,Ointment,5%,SDL,
Lidocaine,Topical solution,4%,SDL,
Lidocaine,Topical spray,10%,SDL,
Lidocaine & Adrenaline,Injection,"Lidocaine 2% + Adrenaline 1:80,000 (12.5 microgram/mL)",SDL, 
Lidocaine & Prilocaine,Cream,Lidocaine 2.5% + Prilocaine 2.5%,SDL,
Lidocaine Hydrochloride ,Gel,2%,SDL,
Lidocaine Hydrochloride ,Injection,1%,SDL,
Lidocaine Hydrochloride ,Oral solution (viscous),2%,SDL,
Lidocaine Hydrochloride ,Injection (preservative-free),"1%, 2%",SDL,
Linagliptin,Tablet,5 mg,MAF,"For patients with type 2 diabetes mellitus and chronic kidney disease stages 3b, 4 or 5"
Linezolid,Infusion,2 mg/mL,MAF,Treatment of patients with culture-positive vancomycin-resistant enterococci (VRE) bloodstream infections
Linezolid,Tablet,600 mg,MAF,Treatment of patients with culture-positive vancomycin-resistant enterococci (VRE) bloodstream infections
Liothyronine Sodium ,Tablet,20 mcg,SDL,
Liquid Paraffin,Oral emulsion,2.5 mL/5 mL,SDL,
Liquid Paraffin,Liquid,-,SDL,
Lisinopril,Tablet,"5 mg, 10 mg, 20 mg",SDL,
Lithium Carbonate,Controlled-release tablet,400 mg,SDL,
Lomustine,Capsule,40 mg,SDL,
Lopinavir & Ritonavir,Oral solution,Lopinavir 80 mg/mL + Ritonavir 20 mg/mL,SDL, 
Lopinavir & Ritonavir,Tablet,Lopinavir 200 mg + Ritonavir 50 mg,SDL, 
Loratadine,Syrup,5 mg/5 mL,SDL,
Loratadine,Tablet,10 mg,SDL,
Lorazepam,Tablet,"0.5 mg, 1 mg",SDL,
Losartan Potassium ,Tablet,"50 mg, 100 mg",SDL,
Lovastatin,Tablet,20 mg,SDL,
Magnesium Carbonate & Sodium Bicarbonate,Oral suspension,"Magnesium Carbonate 150 mg/5 mL + Sodium Bicarbonate 250 mg/5 mL + Aromatic Cardamom Tincture 0.15 mL/5 mL
        ",SDL,
"Magnesium Chloride Hexahydrate, Potassium Chloride & Procaine Hydrochloride",Concentrate for infusion,Magnesium Chloride Hexahydrate 162.5 mg/mL (0.8 mmol/mL) + Potassium Chloride 59.5 mg/mL (0.8 mmol/mL) + Procaine Hydrochloride 13.64 mg/mL (0.05 mmol/mL),SDL,
Magnesium Sulfate,Crystal, -,SDL, 
Magnesium Sulfate,Injection,49.3%,SDL,
Magnesium Sulfate,Injection,49.3% (2 mmol Mg2+/mL),SDL,
Magnesium Sulfate & Glycerin,Syrup,Magnesium Sulfate 35.4% + Glycerin 1.1%,SDL, 
Magnesium Trisilicate,Oral suspension,Magnesium Trisilicate 5% + Magnesium Carbonate 5% + Sodium Bicarbonate 5% ,SDL,
Malathion,Lotion,0.5%,SDL,
Mannitol,Infusion,20%,SDL,
Mebeverine Hydrochloride ,Tablet,135 mg,SDL,
Medroxyprogesterone Acetate,Injection,50 mg/mL,SDL,
Medroxyprogesterone Acetate,Tablet,"5 mg, 10 mg",SDL,
Mefenamic Acid,Capsule,250 mg,SDL,
Mefloquine,Tablet,250 mg,SDL,
Melphalan,Injection,50 mg,SDL,
Melphalan,Tablet,2 mg,SDL,
Memantine,Tablet,10 mg,SDL, 
Mercaptopurine,Tablet,50 mg,SDL,
Meropenem ,Injection,"500 mg, 1 g",SDL,
Mesalazine ,Enema,2 g/30 mL,SDL,
Mesalazine ,Enteric-coated tablet,"250 mg, 400 mg, 500 mg, 800 mg",SDL,
Mesalazine,Granules,"2 g, 4 g",SDL, 
Mesalazine ,Prolonged-release tablet,"500 mg, 1 g",SDL,
Mesalazine ,Suppository,"250 mg, 500 mg, 1 g",SDL,
Mesna,Injection,100 mg/mL,SDL,
Mesna,Tablet,"400 mg, 600 mg",SDL,
Metformin Hydrochloride,Tablet,"250 mg, 500 mg, 850 mg",SDL,
Methadone,Tablet,5 mg,SDL,
Methionine,Oral powder,-,SDL,
Methotrexate,Injection,"50 mg/2 mL, 1 g/10 mL",SDL,
Methotrexate,Injection (preservative-free),50 mg/2 mL,SDL,
Methotrexate ,Tablet,2.5 mg,SDL,
Methoxsalen,Lotion,"0.01%, 0.05%, 0.1%, 0.75%",SDL,
Methoxsalen,Capsule,10 mg,SDL,
Methoxsalen,Tablet ,10 mg,SDL,
Methyl Salicylate,Cream,10%-20%,SDL,
Methyl Salicylate,Solution,25%,SDL,
Methylated Spirit,Topical solution,70%,SDL,
Methyldopa,Tablet,"125 mg, 250 mg",SDL,
Methylphenidate Hydrochloride,Extended-release tablet,"18 mg, 27 mg, 36 mg, 54 mg",MAF,Attention deficit hyperactivity disorder in children and adolescents aged < 18 years old
Methylphenidate Hydrochloride,Long-acting capsule,20 mg,MAF,Attention deficit hyperactivity disorder in children and adolescents aged < 18 years old
Methylphenidate Hydrochloride (Medikinet),Modified-release capsule,"5 mg, 10 mg, 20 mg, 30 mg, 40 mg",SDL, 
Methylphenidate Hydrochloride ,Sustained-release tablet,20 mg,MAF,Attention deficit hyperactivity disorder in children and adolescents aged < 18 years old
Methylphenidate Hydrochloride ,Tablet,10 mg,SDL,
Methylprednisolone (as Sodium Succinate) ,Injection,62.5 mg/mL,SDL,
Metoclopramide Hydrochloride,Injection,5mg/mL,SDL,
Metoclopramide Hydrochloride ,Tablet,10 mg,SDL,
Metronidazole,Infusion,5 mg/mL,SDL,
Metronidazole,Tablet,200 mg,SDL,
Miconazole,Oral gel,2%,SDL,
Miconazole Nitrate ,Cream,2%,SDL,
Midazolam,Injection,"5 mg/mL, 5 mg/5 mL",SDL,
Midodrine Hydrochloride,Tablet,5 mg,SDL,
Mirtazapine,Oral disintegrating tablet,"15 mg, 30 mg",SDL,
Mirtazapine,Tablet,30 mg,SDL,
Mitomycin,Injection,"2 mg, 10 mg",SDL,
Mitoxantrone ,Injection,2 mg/mL,SDL,
Moclobemide,Tablet,150 mg,SDL,
Mometasone Furoate,Nasal spray,0.05%,SDL,
Morphine Sulfate ,Controlled-release tablet,"10 mg, 30 mg",SDL,
Morphine Sulfate ,Injection,10 mg/mL,SDL,
Morphine,Oral solution,"1 mg/mL, 2 mg/mL",SDL,
Morphine,Syrup,1 mg/mL,SDL,
Multivitamin for Paediatrics,Oral solution,"A combination preparation of vitamins, minerals and/or nutrients, which includes at least 3 of the following: Ascorbic acid, Riboflavine, Nicotinamide, Thiamine, Pyridoxine, Calciferol, Cyanocobalamin, Vitamin A",SDL,
Mycophenolate Mofetil,Capsule,250 mg,SDL, 
Mycophenolate Mofetil,Infusion,500 mg,SDL, 
Mycophenolate Mofetil,Tablet,500 mg,SDL, 
Mycophenolate Sodium (Myfortic),Enteric-coated Tablet,"180 mg, 360 mg",MAF,Prevention of organ rejection in patients who have received a kidney transplant and are unable to tolerate mycophenolate mofetil due to gastrointestinal adverse effects
Naloxone Hydrochloride,Injection,0.4 mg/mL,SDL,
Nandrolone Decanoate,Injection,25 mg/mL,SDL,
Naphazoline Hydrochloride & Pheniramine Maleate,Eye drops,Naphazoline Hydrochloride 0.025% + Pheniramine Maleate 0.3%,SDL,
Neomycin Sulfate,Tablet,500 mg,SDL,
"Neomycin, Polymyxin B & Dexamethasone",Ear drops,"Neomycin Sulfate 6,500 international units/mL + Polymyxin B Sulfate 10,000 international units/mL + Dexamethasone Sodium Metasulfobenzoate 1 mg/mL",SDL,
Neostigmine Metilsulfate,Injection,2.5 mg/mL,SDL,
Netupitant & Palonosetron,Capsule,Netupitant 300 mg & Palonosetron 0.5 mg,MAF,Prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
Nevirapine,Extended-release tablet,400 mg,SDL, 
Nevirapine,Tablet,200 mg,SDL, 
Nicotinic Acid,Tablet,50 mg,SDL,
Nifedipine,Extended-release tablet,"30 mg, 60 mg",SDL,
Nifedipine,Tablet,10 mg,SDL,
Nifedipine ,Capsule,"5 mg, 10 mg",SDL,
Nitrazepam,Tablet,5 mg,SDL,
Nitrofurantoin,Tablet,50 mg,SDL,
Norepinephrine,Concentrate for infusion,4 mg/4 mL,SDL,
Norethisterone,Tablet,5 mg,SDL,
Nortriptyline,Capsule,"10 mg, 25 mg",SDL,
Nystatin,Oral suspension,"100,000 units/mL",SDL,
Nystatin,Vaginal tablet,"100,000 units",SDL,
Olanzapine ,Oral disintegrating tablet,"5 mg, 10 mg",SDL,
Olanzapine ,Tablet,"5 mg, 10 mg",SDL,
Olive Oil,Ear drops,-,SDL,
Omalizumab,Injection,150 mg,MAF,"Checklist to be completed.As an add-on therapy to H1-antihistamines for treating severe chronic spontaneous urticaria (CSU) in patients aged 12 years and older, with a mean weekly Urticaria Activity Score (UAS7) of 28 and above, despite the use of, or who are intolerant to, four-times registered dose of second generation non-sedating H1-antihistamines.A maximum of six 300 mg doses of omalizumab should be administered for each treatment course. Re-treatment with omalizumab can be considered upon relapse for patients who achieve an adequate response during the previous treatment course. Adequate response to omalizumab is defined as a UAS7 score of six or below while on treatment."
Omeprazole,Capsule,20 mg,SDL,
Omeprazole,Injection ,40mg,SDL, 
Ondansetron,Injection,2 mg/mL,SDL,
Ondansetron,Tablet,8 mg,SDL,
Oral Rehydration Salts,Effervescent tablet,-,SDL,
Oral Rehydration Salts,Oral powder for reconstitution,-,SDL,
Oxaliplatin,Concentrate for infusion,"50 mg/10 mL, 100 mg/50 mL",SDL,
Oxaliplatin,Infusion,"50 mg, 100 mg",SDL,
Oxybutynin Chloride ,Tablet,5 mg,SDL,
Oxymetazoline Hydrochloride ,Nasal drops,"0.01%, 0.025%, 0.05%",SDL,
Oxymetazoline Hydrochloride ,Nasal spray,"0.025%, 0.05%",SDL,
Oxytocin,Injection,10 international units/mL,SDL,
Oxytocin & Ergometrine Maleate,Injection,Oxytocin 5 international units/mL + Ergometrine Maleate 0.5 mg/mL,SDL,
Paclitaxel,Concentrate for infusion,6 mg/mL,SDL,
Pamidronate Disodium,Infusion,"30 mg, 90 mg",MAF,"1) Treatment of metastatic bone lesions from breast cancer and advanced multiple myeloma
           2) Treatment of hypercalcaemia of malignancy"
Pancuronium Bromide ,Concentrate for infusion,2 mg/mL,SDL,
Pantopazole,Injection,40 mg,SDL, 
Paracetamol,Infusion,"500 mg/50 mL, 1,000 mg/100 mL",SDL,
Paracetamol,Oral suspension,120 mg/5 mL,SDL,
Paracetamol,Rectal suppository,"125 mg, 250 mg, 325 mg, 650 mg",SDL,
Paracetamol,Tablet,"120 mg, 500 mg",SDL,
Paracetamol & Orphenadrine Citrate,Tablet,Paracetamol 450 mg + Orphenadrine Citrate 35 mg,SDL,
Paraffin,Liquid,-,SDL,
Paraffin Soft & Paraffin Liquid,Emulsion,Soft Paraffin 50% + Liquid Paraffin 50%,SDL,
Peginterferon Alfa-2a ,Injection,"135 mcg/0.5 mL, 180 mcg/0.5 mL",MAF,"1) Treatment, in combination with ribavirin, of chronic hepatitis C infection in naive adult patients and patients who have failed previous treatment with interferon alfa (pegylated or non-pegylated) alone or in combination therapy with ribavirin
           2) Treatment for a duration of up to 48 weeks, in adult patients with HBeAg-positive and HBeAg-negative chronic hepatitis B infection with compensated liver disease and evidence of viral replication and liver inflammation."
Penicillamine,Capsule,250 mg,SDL,
Pethidine Hydrochloride ,Injection,50 mg/mL,SDL,
Phenazopyridine Hydrochloride ,Tablet,100 mg,SDL,
Phenobarbital Sodium ,Injection,200 mg/mL,SDL,
Phenobarbitone,Tablet,"10 mg, 30 mg, 60 mg",SDL,
Phenol (in almond oil),Injection,5%,SDL,
Phenoxymethylpenicillin,Tablet,250 mg,SDL,
Phenylephrine Hydrochloride,Single-use eye drops,"2.5%, 10%",SDL,
Phenylephrine Hydrochloride ,Eye drops,"2.5%, 10% ",SDL,
Phenytoin,Oral suspension,125 mg/5 mL,SDL,
Phenytoin Sodium,Injection,50 mg/mL,SDL,
Phenytoin Sodium ,Capsule,"30 mg, 100 mg",SDL,
Physostigmine Salicylate,Injection,1 mg/mL,SDL,
Phytomenadione,Injection,10 mg/mL,SDL,
Pilocarpine Hydrochloride ,Eye drops,"2%, 4%",SDL,
Pilocarpine Nitrate ,Single-use eye drops,2%,SDL,
Piperacillin & Tazobactam ,Injection,Piperacillin 4 g + Tazobactam 0.5 g,SDL,
Piroxicam,Capsule,"10 mg, 20 mg",SDL,
Plasma-derived Factor VIII,Injection,"250 international units, 500 international units, 1000 international units",SDL, 
Plasma-derived Factor VIII & Von Willebrand Factor,Injection,"Plasma-derived Factor VIII 250 international units, 500 international units, 1000 international units + Von Willebrand Factor range 100 international units to 3200 international units",SDL, 
Podophyllum Resin,Paint,"0.25%, 0.5%",SDL,
Poractant alfa,Intratracheal suspension,120 mg/1.5 mL,SDL, 
Posaconazole,Delayed-release tablet,100 mg,MAF,For prophylaxis of invasive fungal infections in high risk patients (such as anticipated to have prolonged neutropenia) and haematopoietic stem cell transplant recipients
Posaconazole,Oral suspension,40 mg/mL,MAF,For prophylaxis of invasive fungal infections in high risk patients (such as anticipated to have prolonged neutropenia) and haematopoietic stem cell transplant recipients
Potassium Chloride,Slow-release tablet,600 mg,SDL,
Potassium Chloride,Oral solution,500 mg/5 mL ,SDL,
Potassium Chloride,Concentrate for infusion,7.45%,SDL,
Potassium Chloride,Infusion,"0.1 mmol/mL, 0.2 mmol/mL, 0.4 mmol/mL",SDL,
Potassium Chloride & Sodium Chloride,Infusion,Potassium Chloride 0.15% + Sodium Chloride 0.9%,SDL,
Potassium Citrate,Oral solution,500 mg/5 mL,SDL,
Potassium Permanganate,Crystals,100%,SDL,
Potassium Permanganate,Topical solution,0.1%,SDL,
Potassium Phosphate Monobasic ,Concentrate for infusion,1 mmol/mL (0.1361 g/mL),SDL,
Povidone-Iodine,Topical solution,10%,SDL,
Pralidoxime Chloride ,Injection,500 mg/20 mL,SDL,
Pramipexole Dihydrochloride Monohydrate,Tablet,"0.125 mg, 1 mg",SDL,
Pravastatin Sodium,Tablet,20 mg,SDL,
Prazosin,Tablet,"1 mg, 5 mg",SDL,
Prednisolone,Syrup,10 mg/5 mL,SDL,
Prednisolone,Tablet,"1 mg, 5 mg, 20 mg",SDL,
Primaquine,Tablet,"7.5 mg, 15 mg",SDL,
Probenecid,Tablet,500 mg,SDL,
Procainamide Hydrochloride,Injection,100 mg/mL,SDL,
Procaine Hydrochloride ,Lotion (in spirit 70%),2%,SDL,
Procarbazine,Capsule,50 mg,SDL,
Prochlorperazine Maleate ,Tablet,5 mg,SDL,
Prochlorperazine Mesilate,Injection,12.5 mg/mL,SDL,
Progesterone,Injection,50 mg/mL,SDL,
Promethazine Hydrochloride ,Syrup,5 mg/5mL,SDL,
Promethazine Hydrochloride ,Injection,25 mg/mL,SDL,
Promethazine Hydrochloride ,Syrup,5 mg/5 mL,SDL,
Promethazine Theoclate,Tablet,25 mg,SDL,
Propantheline Bromide,Tablet,15 mg,SDL,
Propafenone Hydrochloride,Tablet,150 mg,SDL, 
Proparacaine Hydrochloride ,Eye drops,0.5%,SDL,
Propofol,Injection,10 mg/mL,SDL,
Propranolol Hydrochloride,Injection,1 mg/mL,SDL,
Propranolol Hydrochloride ,Tablet,"10 mg, 40 mg, 80 mg",SDL,
Propylene Glycol,Solution,40%,SDL,
Propylthiouracil,Tablet,50 mg,SDL,
Protamine Sulfate,Injection,1% (10 mg/mL),SDL,
Pyrazinamide,Tablet,500 mg,SDL,
Pyridostigmine Bromide,Tablet,"10 mg, 60 mg",SDL,
Pyridoxine Hydrochloride,Tablet,"10 mg, 50 mg",SDL,
Pyrimethamine,Tablet,25 mg,SDL,
Quetiapine ,Tablet,"25 mg, 100 mg, 200 mg",SDL,
Quinine Sulfate ,Tablet,300 mg,SDL,
Rabies Virus Vaccine (Inactivated) ,Injection,Minimum 2.5 international units,SDL,
Ranitidine,Injection,50 mg/2 mL,SDL, 
Raltegravir,Tablet,"400 mg, 600 mg",MAF,In combination with other antiretroviral agents for the treatment of HIV-1 infection
Recombinant Factor VIII (Xyntha),Injection,"250 international units, 500 international units, 1000 international units, 2000 international units",SDL, 
Ribavirin,Capsule,200 mg,MAF,Treatment of chronic hepatitis C infection (all genotypes)
Ribavirin,Tablet,200 mg,MAF,Treatment of chronic hepatitis C infection (all genotypes)
Rifampicin,Capsule,"150 mg, 300 mg",SDL,
Rifampicin,Suspension,100 mg/5 mL,SDL, 
Rifaximin,Tablet,550 mg,SDL, 
Rilpivirine,Tablet,25 mg,SDL, 
Risedronate Sodium ,Tablet,"5 mg, 35 mg",MAF,"1) For patients with osteoporosis (T-score ≤ -2.5)
           2) For patients with osteopenia (T-score ≤ -1.5) and a history of non-trauma induced fracture"
Risperidone,Oral solution,1 mg/mL,SDL,
Risperidone,Tablet,"0.5 mg, 1 mg, 2 mg",SDL,
Ritonavir,Tablet,100 mg,SDL, 
Rituximab (MabThera),Concentrate for infusion,"100 mg/10 mL, 500 mg/50 mL",MAF,"1) Treatment of patients with CD20 positive diffuse large B cell lymphoma
           2) Treatment of patients with CD20 positive follicular non-Hodgkin's lymphoma"
Rituximab biosimilar (Truxima),Concentrate for infusion,"100 mg/10 mL, 500 mg/50 mL",SDL, 
Rivaroxaban,Tablet,"15 mg, 20 mg",MAF,"1) Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF)* and CHA2DS2-VASc score of 1 or more for men, and 2 or more for women
           *This excludes patients with rheumatic mitral stenosis or prosthetic heart valves
           2) Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE in adults. MAF assistance does not apply to patients with isolated distal DVT"
Rivastigmine,Transdermal patch,"4.6 mg/24 hr, 9.5 mg/24 hr, 13.3 mg/24 hr",MAF,"1) Rivastigmine patch formulation (4.6 mg/24 hr and 9.5 mg/24 hr) for the treatment of moderately severe dementia associated with Parkinson's disease in patients who have behavioural symptoms
           2) Rivastigmine patch formulation (4.6 mg/24 hr, 9.5 mg/24 hr and 13.3 mg/24 hr) for the treatment of moderately severe dementia associated with Alzheimer's disease in patients who have behavioural symptoms
        "
Ropinirole,Tablet,"0.25 mg, 1 mg, 2 mg",SDL,
Salbutamol,Inhaler,100 mcg/dose,SDL,
Salbutamol,Nebulisation solution,0.5%,SDL,
Salbutamol,Concentrate for infusion,5 mg/5 mL,SDL,
Salbutamol,Oral liquid,2 mg/5 mL,SDL,
Salbutamol,Tablet,2 mg,SDL,
Salicylic Acid,Cream,"2%, 20%",SDL,
Salicylic Acid,Ointment,"1%, 2%, 5%, 10%, 20%, 40%",SDL,
Salicylic Acid & Lactic Acid ,Topical solution,Salicylic Acid 16.7% + Lactic Acid 16.7% Collodion,SDL,
Salmeterol & Fluticasone Propionate,Inhaler,"Salmeterol 25 mcg/dose + Fluticasone Propionate 50 mcg/dose, Salmeterol 25 mcg/dose + Fluticasone Propionate 125 mcg/dose, Salmeterol 25 mcg/dose + Fluticasone Propionate 250 mcg/dose",SDL,
Salmeterol & Fluticasone Propionate,Powder inhaler,"Salmeterol 50 mcg/dose + Fluticasone Propionate 100 mcg/dose, Salmeterol 50 mcg/dose + Fluticasone Propionate 250 mcg/dose, Salmeterol 50 mcg/dose + Fluticasone Propionate 500 mcg/dose",SDL,
Sea Snake Venom Antiserum,Concentrate for infusion,"1,000 units/dose",SDL,
Selenium Sulfide,Topical suspension,2.5%,SDL,
Sennosides ,Tablet,7.5 mg,SDL,
Sertraline,Tablet,50 mg,SDL,
Sevelamer Carbonate,Tablet,800 mg,MAF,"Treatment of hyperphosphataemia in patients with chronic kidney disease who have persistent hyperphosphataemia despite optimising treatment with calcium-based phosphate binders, or who are unable to tolerate calcium-based phosphate binders due to hypercalcaemia."
Silicone Cream,Cream,"Dimethicone 10%, Chlorocresol 0.1%",SDL,
Simeticone ,Oral suspension,100 mg/mL,SDL,
Simvastatin ,Tablet,"10 mg, 20 mg",SDL,
Sirolimus,Tablet,"0.5 mg, 1 mg, 2 mg",MAF,"For kidney transplant immunosuppression in patients with:
           1) Evidence of CNI-induced nephrotoxicity on allograft biopsy OR
           2) Elevated serum creatinine levels precluding the achievement of optimal therapeutic blood levels of CNI OR
           3) History of CNI drug hypersensitivity"
Sirolimus,Oral solution,1 mg/mL,MAF,"For kidney transplant immunosuppression in patients with:
           1) Evidence of CNI-induced nephrotoxicity on allograft biopsy OR
           2) Elevated serum creatinine levels precluding the achievement of optimal therapeutic blood levels of CNI OR
           3) History of CNI drug hypersensitivity"
"Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate ",Oral suspension,Sodium Alginate 500 mg/10 mL + Sodium Bicarbonate 267 mg/10 mL + Calcium Carbonate 160 mg/10 mL,SDL,
Sodium Benzoate,Injection,2 g/10 mL,SDL, 
Sodium Benzoate,Powder,"5 g, 1 kg",SDL, 
Sodium Benzoate,Tablet,500 mg,SDL, 
Sodium Bicarbonate,Infusion,"4.2%, 8.4%",SDL,
Sodium Bicarbonate,Injection,"4.2%, 8.4%",SDL,
Sodium Bicarbonate,Capsule,500 mg,SDL,
Sodium Bicarbonate,Powder,Minimum 99%,SDL,
Sodium Bicarbonate & Sodium Chloride,Powder,9 parts Sodium Bicarbonate + 1 part Sodium Chloride,SDL,
Sodium Calcium Edetate,Injection,500 mg/10 mL,SDL,
Sodium Chloride,Infusion,"0.45%, 0.9%, 3%, 20%",SDL,
Sodium Chloride,Irrigation solution,0.9%,SDL,
Sodium Chloride,Injection,"0.45%, 0.9%, 3%, 20%",SDL,
Sodium Chloride,Eye drops,"0.9%, 5%",SDL,
Sodium Chloride,Eye ointment,5%,SDL,
Sodium Chloride & Dextrose ,Sustained-release tablet,Sodium Chloride 500 mg + Dextrose 200 mg ,SDL,
"Sodium Chloride, Calcium Chloride Dihydrate & Potassium Chloride ",Infusion,Sodium Chloride 8.6 g/L + Calcium Chloride Dihydrate 0.33 g/L + Potassium Chloride 0.3 g/L,SDL,
Sodium Nitrite,Injection,3%,SDL,
Sodium Nitroprusside,Injection, 50 mg/2 ml ,SDL,
Sodium Polystyrene Sulfonate,Oral suspension,15 g/60 mL,SDL,
Sodium Polystyrene Sulfonate,Powder for oral suspension,99%,SDL,
Sodium Tetradecyl Sulfate,Injection,"1%, 3%",SDL,
Sodium Thiosulfate,Injection,25%,SDL,
Sodium Valproate,Controlled-release tablet,"200 mg, 300 mg, 500 mg",SDL,
Sodium Valproate,Enteric-coated tablet,200 mg ,SDL,
Sodium Valproate,Injection,400 mg,SDL,
Sodium Valproate,Syrup,200 mg/5 mL,SDL,
Sofosbuvir & Velpatasvir,Tablet,Sofosbuvir 400 mg + Velpatasvir 100 mg, MAF,"Treatment of chronic hepatitis C infection (all genotypes) in treatment-naïve, or pegylated interferon plus ribavirin (PR)-experienced or NS3/4A protease inhibitor (boceprevir, simeprevir, telaprevir)-experienced adults.Sofosbuvir/velpatasvir should be used in line with the recommended treatment regimen and duration:• 12 weeks’ treatment of sofosbuvir/velpatasvir for patients with hepatitis C virus (all genotypes) without cirrhosis or with compensated cirrhosis (Child-Pugh A). For patients with genotype 3, the addition of ribavirin may be considered in patients who are treatment-experienced or have compensated cirrhosis (Child-Pugh A).• 12 weeks’ treatment of sofosbuvir/velpatasvir in combination with ribavirin for patients with hepatitis C virus (all genotypes) with decompensated cirrhosis (Child-Pugh B or C)."
Solifenacin Succinate,Tablet ,5 mg ,SDL , 
Somatostatin (as Acetate) ,Infusion,3 mg,SDL,
Somatropin,Prefilled pen,"5 mg/1.5 mL, 10 mg/1.5 mL",MAF,"Treatment of children with short stature due to conditions associated with growth failure
           *Somatropin is not recommended for the treatment of idiopathic short stature"
Somatropin,Injection,"3.33 mg, 4 mg, 6 mg",MAF,"Treatment of children with short stature due to conditions associated with growth failure
           *Somatropin is not recommended for the treatment of idiopathic short stature"
Sotalol hydrochloride,Tablet,80 mg,SDL, 
Spironolactone,Tablet,25 mg,SDL,
Stiripentol,Capsule,"250 mg, 500 mg",MAF,Treatment of status epilepticus in Dravet syndrome
Stiripentol,Oral suspension,"250 mg, 500 mg",MAF,Treatment of status epilepticus in Dravet syndrome
Streptokinase,Infusion,1.5 million international units,SDL,
Streptomycin,Injection,1 g,SDL,
Sulfadiazine Silver,Cream,1%,SDL,
Sulfamethoxazole & Trimethoprim,Concentrate for infusion,Sulfamethoxazole 80 mg/mL + Trimethoprim 16 mg/mL,SDL,
Sulfamethoxazole & Trimethoprim,Suspension,Trimethoprim 40 mg/5 mL + Sulphamethoxazole 200 mg/5 mL,SDL,
Sulfamethoxazole & Trimethoprim,Tablet,"Trimethoprim 20 mg + Sulphamethoxazole 100 mg, Trimethoprim 80 mg + Sulphamethoxazole 400 mg",SDL,
Sulfasalazine,Enteric-coated tablet,500 mg,SDL,
Sulphur & Salicylic Acid ,Cream,Sulphur 4% + Salicylic Acid 2%,SDL,
"Sulphur, Resorcinol & Calamine",Lotion,Sulphur 4% + Resorcinol 2% + Calamine 10%,SDL,
"Sulphur, Zinc Oxide, Resorcinol & Calamine",Cream,Sulphur 4% + Zinc Oxide 8% + Resorcinol 2% + Calamine 8%,SDL,
Sulpiride,Tablet,200 mg,SDL,
Sumatriptan,Tablet,50 mg,SDL,
Suxamethonium Chloride,Injection,50 mg/mL,SDL,
Tacrolimus,Prolonged-release capsule,"0.5 mg, 1 mg, 5 mg",SDL,
Tacrolimus,Capsule,"0.5 mg, 1 mg, 5 mg",SDL,
Tacrolimus,Concentrate for infusion,5 mg/mL,SDL, 
Tamoxifen,Tablet,"10 mg, 20 mg",SDL,
Telmisartan,Tablet,"40 mg, 80 mg",SDL, 
Temozolomide,Capsule,"20 mg, 100 mg",SDL,
Tenofovir Disoproxil Fumarate,Tablet ,300 mg,SDL,
Terazosin,Tablet,"2 mg, 5 mg",SDL,
Testosterone Cipionate,Injection,100 mg/mL,SDL,
Tetanus Immunoglobulin (Human),Injection,250 units/dose,SDL,
Tetanus Toxoid Vaccine,Injection,Minimum 40 international units/0.5 mL,SDL,
Tetracycline Hydrochloride ,Ointment,3%,SDL,
Tetracycline Hydrochloride ,Capsule,250 mg,SDL,
Thalidomide,Capsule,50 mg,SDL, 
Theophylline,Sustained-release tablet,"125 mg, 200 mg, 250 mg, 300 mg",SDL,
Theophylline,Syrup,80 mg/15 mL,SDL,
Thiamine Hydrochloride ,Injection,"100 mg/2 mL, 100 mg/mL",SDL,
Thiamine Hydrochloride ,Tablet,10 mg,SDL,
Thiopental Sodium ,Injection,"0.5 g, 1 g",SDL,
Thrombin,Topical solution,"5,000 international units/5 mL",SDL,
Ticagrelor,Tablet,90 mg,MAF ,"Prevention of thrombotic events (cardiovascular death, myocardial infarction and stroke) in adults with acute coronary syndromes, that is, people:• with ST-segment-elevation myocardial infarction (STEMI); or• with non-ST-segment-elevation myocardial infarction (NSTEMI); or• with unstable angina requiring hospitalisation - defined as ST or T wave changes on electrocardiogram suggestive of ischaemia plus one of the following characteristics:- age 60 years and older;- previous myocardial infarction;- previous coronary artery bypass grafting (CABG);- coronary artery disease with stenosis of 50% or more in at least two vessels;- previous ischaemic stroke;- previous transient ischaemic attack;- carotid stenosis of at least 50%;- cerebral revascularisation;- diabetes mellitus;- peripheral arterial disease; or- chronic renal dysfunction, defined as a creatinine clearance of less than 60 ml per minute per 1.73m2 of body surface area.Ticagrelor should be used in combination with low-dose aspirin for up to 12 months."
Ticlopidine Hydrochloride ,Tablet,250 mg,SDL,
Timolol Maleate,Eye drops,"0.25%, 0.5%",SDL,
Tioguanine,Tablet,40 mg,SDL,
Tolbutamide,Tablet,500 mg,SDL,
Tolterodine Tartrate ,Extended-release capsule,4 mg,SDL,
Tolterodine Tartrate ,Tablet,"1 mg, 2 mg",SDL,
Topiramate,Tablet,"25 mg, 50 mg, 100 mg",SDL,
Tramadol Hydrochloride,Capsule,50 mg,SDL,
Tramadol Hydrochloride,Tablet,50 mg,SDL,
Tranexamic Acid ,Injection ,100 mg/mL,SDL,
Tranexamic Acid ,Tablet,500 mg,SDL,
Trastuzumab Biosimilar (Ogivri),Injection,440 mg ,SDL,
Tretinoin,Capsule,10 mg,SDL,
Triamcinolone Acetonide,Injection,10 mg/mL,SDL,
Triamcinolone Acetonide,Nasal spray,55 mcg/dose,SDL,
Triamterene & Hydrochlorothiazide ,Tablet,Triamterene 50 mg + Hydrochlorothiazide 25 mg,SDL,
Trifluoperazine,Tablet,"1 mg, 5 mg",SDL,
Trimethoprim,Oral suspension,50 mg/5 mL,SDL,
Trimethoprim,Tablet,100 mg,SDL,
Tropicamide,Eye drops,"0.5%, 1% ",SDL,
Tropicamide,Single-use eye drops,1%,SDL,
Umeclidinium ,Powder inhaler,62.5 mcg/dose,SDL,
Umeclidinium & Vilanterol,Powder inhaler,Umeclidinium 62.5 mcg/dose + Vilanterol 25 mcg/dose,SDL,
Urea,Cream,"5%, 10% ",SDL,
Ursodeoxycholic Acid,Capsule,250 mg ,SDL , 
Ursodeoxycholic Acid,Suspension,50 mg/mL,SDL, 
Ursodeoxycholic Acid,Tablet,500 mg ,SDL , 
Valganciclovir,Tablet,450 mg,SDL, 
Valsartan,Tablet,"80 mg, 160 mg",SDL,
Vancomycin,Infusion,500 mg,SDL,
Vasopressin ,Injection,20 pressor units/mL,SDL,
Venlafaxine,Extended-release capsule,"75 mg, 150 mg",SDL,
Verapamil Hydrochloride,Injection,2.5 mg/mL,SDL,
Verapamil Hydrochloride,Tablet,40 mg,SDL,
Vinblastine Sulfate,Injection,10 mg,SDL,
Vincristine Sulfate,Injection,1 mg,SDL,
Vitamin A,Capsule,"10,000 units",SDL,
Vitamin B Complex,Injection,Thiamine Hydrochloride 10 mg/2 mL + Sodium Riboflavin Phosphate 4 mg/2 mL + Nicotinic Acid 40 mg/2 mL + Panthenol 6 mg/2 mL + Biotin 5 mg/2 mL + Pyridoxine Hydrochloride 4 mg/2 mL + Cyanocobalamin 8 mcg/2 mL,SDL,
Vitamin B Complex,Tablet,Thiamine 3 mg + Riboflavine 1.5 mg + Nicotinamide 10 mg + Pyridoxine 0.5 mg,SDL,
Voriconazole ,Infusion,200 mg,MAF,"1) Treatment of invasive aspergillosis
           2) Treatment of candidaemia in non-neutropenic patients
           3) Treatment of fluconazole-resistant candidiasis
           4) Treatment of serious infections from Scedosporium and Fusarium species"
Voriconazole ,Oral suspension,40 mg/mL,MAF,"1) Treatment of invasive aspergillosis
           2) Treatment of candidaemia in non-neutropenic patients
           3) Treatment of fluconazole-resistant candidiasis
           4) Treatment of serious infections from Scedosporium and Fusarium species"
Voriconazole ,Tablet,"50 mg, 200 mg",MAF,"1) Treatment of invasive aspergillosis
           2) Treatment of candidaemia in non-neutropenic patients
           3) Treatment of fluconazole-resistant candidiasis
           4) Treatment of serious infections from Scedosporium and Fusarium species"
Warfarin Sodium,Tablet,"1 mg, 3 mg, 5 mg",SDL,
White Soft Paraffin,Ointment,-,SDL,
Zidovudine,Capsule,100 mg,SDL, 
Zoledronic Acid,Infusion,5 mg/100 mL,MAF,"1) For patients with osteoporosis (T score ≤ -2.5) and who are unable to tolerate or follow the administration instructions for oral bisphosphonates
           2) For patients with FRAX of ≥ 20 for major osteoporotic fractures and ≥ 3 for hip fractures and who are unable to tolerate or follow the administration instructions for oral bisphosphonates"
Zoledronic Acid,Infusion,4 mg,MAF,"1) Treatment of metastatic bone lesions from solid tumours and multiple myeloma
           2) Treatment of hypercalcaemia of malignancy"
Zuclopenthixol Acetate,Injection,50 mg/mL,SDL,
Zuclopenthixol Decanoate,Injection,200 mg/mL,SDL,
